Companies: 10,795·Total market cap: $144.5T
Abeona Therapeutics Inc.

Abeona Therapeutics Inc.

ABEONASDAQHealthcare● Active
$5.38
$-0.08(-1.47%)
Market Cap$306633875
P/E Ratio
52W High$7.54
52W Low$4

Abeona Therapeutics Inc.(ABEO)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

abeo · 股价预测 · 9 位分析师(近3月)· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 9 位华尔街分析师

SellBuy

Buy

9 位分析师

共识

评级分布

Strong Buy
0
Buy
6
Hold
3
Sell
0
Strong Sell
0
合计: 9 · 买入占比: 66.7%

12 个月目标价

High

$17.00

Consensus

$17.00

+216.0% upside

Low

$17.00

Median: $17 · Last Close: $5.38

Abeona Therapeutics Inc.(ABEO)的分析师共识为 Buy,基于过去 3 个月内 9 位华尔街分析师的评级。ABEO 的 12 个月平均目标价为 $17.00,相对当前价 $5.38 代表 +216.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$5.400.36%

1-day model range: $5.37–$5.43. Peak: $5.43 (+0.36%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$5-5.5%
2028$5-8.4%
2029$5-9.9%
2030$5-10.7%
2031-11.2%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%7%50%
6Buy
1Neutral
7Sell
RSI (14)50.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · ABEO · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$5.60SELL
MA 10$5.64SELL
MA 20$5.57SELL
MA 50$5.37BUY
MA 100$5.19BUY
MA 200$5.29BUY
Current $ABEO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.55SELL
EMA 10$5.58SELL
EMA 20$5.57SELL
EMA 50$5.43SELL
EMA 100$5.31BUY
EMA 200$5.33BUY
Current $ABEO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-05-28
Maintains
BuyBuy
HC Wainwright & Co.2026-03-19
Maintains
BuyBuy
HC Wainwright & Co.2026-03-10
Maintains
BuyBuy
HC Wainwright & Co.2025-10-13
Maintains
BuyBuy
HC Wainwright & Co.2025-08-18
Maintains
BuyBuy
Oppenheimer2025-08-15
Maintains
OutperformOutperform
HC Wainwright & Co.2025-07-16
Maintains
BuyBuy
HC Wainwright & Co.2025-07-14
Maintains
BuyBuy
Stifel2025-05-16
Maintains
BuyBuy
HC Wainwright & Co.2025-04-30
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Abeona Therapeutics Inc. (ABEO) stock. Of the recent 39 rating actions, 1 were upgrades and 4 were downgrades. 9 analysts currently cover ABEO.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

ABEO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$66M

↓ 68.6% YoY

Revenue Next Year

$140M

↑ 110.6% YoY

EPS This Year

$-0.72

EPS Next Year

$-0.07

↓ 91.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ABEO EPS of $-0.72 for the current fiscal year, based on estimates from 5 analysts. The ABEO revenue forecast is $66M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ABEO 股价预测由两类独立数据源支撑:来自 9 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ABEO 的共识目标价为 $17.00(+216.0% 上行空间),分析师共识为 Buy。

ABEO 的短期预测(明日)为 $5.40(+0.36%)。 ABEO 对 2027 年的股价预测均值为 $5。 ABEO 对 2030 年的预测区间为 $5–$5。

Abeona Therapeutics Inc. 在 NASDAQ 上市,代码 ABEO。ABEO 在 2027 年的整体展望偏积极,在覆盖分析师中约 67% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ABEO 预测 · 8 个问题

根据 9 位华尔街分析师,ABEO 的 12 个月平均目标价为 $17.00,最高 $17.00、最低 $17.00。若有图表,中位目标价可在上方查看。相对当前价 $5.38,隐含约 +216.0% 的上行空间。

ABEO 目标价ABEO 分析师目标价ABEO 12个月目标价目标价 ABEO

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.